Secondary Logo

Journal Logo

May 1, 2022 - Volume 36 - Issue 6

  • JA Levy

    Roel A. Coutinho
    Sarah L. Rowland-Jones
    Michael S. Saag
  • 0269-9370
  • 1473-5571
  • 15 / year
  • 14 of 36 Virology
    32 of 92 Infectious Diseases
    84 of 162 Immunology
  • 4.177

​​​New Special Issue

AIDS V35 Suppl 2 S127 image.jpg

We are pleased to announce the supplement publication  "Antiretroviral treatment optimization – 2021 and beyond"a collection of articles in a special issue of the journal, AIDS.

What have we learned from antiretroviral treatment optimization efforts over the last 5 years? A reflection on progress made in guiding regimen changes to public health programmes, and the challenges facing selection of newer agents.

Supplement Editors: Francois W.D. Venter and Andrew Hill

Figure: Younger age and unemployment predicted poorer adherence in ADVANCE. McCluskey et al. AIDS 35(Suppl. 2):S127-S135.

Current Issue Highlights

Decreased hepatitis B virus vaccine response among HIV-positive infants compared with HIV-negative infants in Botswana

Shaver, Zachary M.; Anderson, Motswedi; Bhebhe, Lynnette; More

AIDS. 36(6):755-762, May 1, 2022.

Do partner services linked to molecular clusters yield people with viremia or new HIV?

Schneider, John A.; Hayford, Christina; Hotton, Anna; More

AIDS. 36(6):845-852, May 1, 2022.

Risk factors for atrial fibrillation in a multicenter United States clinical cohort of people with HIV infection

Nance, Robin M.; Delaney, Joseph A.C.; Floyd, James S.; More

AIDS. 36(6):903-905, May 1, 2022.